KeyBanc raised the firm’s price target on Phreesia (PHR) to $30 from $28 and keeps an Overweight rating on the shares. The firm notes ...

DA Davidson analyst William Jellison keeps a Buy rating and $36 price target on Phreesia (PHR) while naming the company the firm’s 2025 top ...

Navy data scientists built the tool to help Adm. Franchetti and her staff track top-priority topics with a few clicks.

76.5% of OptimizeRx shares are owned by institutional investors. Comparatively, 92.1% of Phreesia shares are owned by institutional investors. 6.1% of OptimizeRx shares are owned by insiders.

Healthcare software as a service (SaaS) company Phreesia is notifying over 910,000 people that their personal and health data was exposed in a May breach of its subsidiary ConnectOnCall ...

Phreesia had a negative net margin of 25.73% and a negative return on equity of 39.34%. The company had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million.

Phreesia (PHR) closed the last trading session at $23.84, gaining 25.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...

Modern cars often come equipped with features whose functions we might not understand, such as the plastic spherical detail ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...